Digital Temperature Control for an Hyperthermic Intraperitoneal Chemotherapy Equipment

This paper presents the design of a digital temperature controller for cytostatic solution used in hyperthermic intraperitoneal chemotherapy (HIPEC). Cytoreductive surgery and HIPEC technique, i.e. Regional chemotherapy using cytostatic drugs at high temperatures of 42-43°C, represents a treatment technique for cancer patients suffering of peritoneal carcinomatosis. The main challenge is to maintain the desired temperature of the cytostatic solution in the intraperitoneal cavity, thus, avoiding local abdominal injuries and systemic hyperthermia. In order to maintain the adequate temperature a digital controller is designed using the Dahlin algorithm, a model based design technique.

[1]  Zhang Zhi-Gang,et al.  Dahlin algorithm design and simulation for time-delay system , 2009, 2009 Chinese Control and Decision Conference.

[2]  P. Sugarbaker,et al.  Pharmacologic rationale for treatments of peritoneal surface malignancy from colorectal cancer. , 2010, World journal of gastrointestinal oncology.

[3]  P. Sugarbaker Cytoreductive Surgery Plus Hyperthermic Perioperative Chemotherapy for Selected Patients with Peritoneal Metastases from Colorectal Cancer: A New Standard of Care or an Experimental Approach? , 2012, Gastroenterology research and practice.

[4]  Weidong Zhang,et al.  Comparison of several well-known controllers used in process control. , 2003, ISA transactions.

[5]  D. Sargent,et al.  Treatment of colorectal peritoneal carcinomatosis with systemic chemotherapy: a pooled analysis of north central cancer treatment group phase III trials N9741 and N9841. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  J. Spratt,et al.  Clinical delivery system for intraperitoneal hyperthermic chemotherapy. , 1980, Cancer research.

[7]  M. Flessner Pharmacokinetic problems in peritoneal drug administration: an update after 20 years , 2016, Pleura and peritoneum.

[8]  Nadine Gottschalk,et al.  Computer Controlled Systems Theory And Design , 2016 .

[9]  J. Faure,et al.  Peritoneal carcinomatosis from non‐gynecologic malignancies , 2000, Cancer.

[10]  M. Flessner,et al.  Pharmacokinetic problems in peritoneal drug administration: tissue penetration and surface exposure. , 1997, Journal of the National Cancer Institute.

[11]  P. Wust,et al.  Regional hyperthermia of the abdomen in conjunction with chemotherapy for peritoneal carcinomatosis: Evaluation of two annular-phased-array applicators , 2008, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[12]  C. Germer,et al.  Evaluation of Best Supportive Care and Systemic Chemotherapy as Treatment Stratified according to the retrospective Peritoneal Surface Disease Severity Score (PSDSS) for Peritoneal Carcinomatosis of Colorectal Origin , 2010, BMC Cancer.

[13]  J. Beijnen,et al.  Population Pharmacokinetics and Pharmacodynamics of Mitomycin During Intraoperative Hyperthermic Intraperitoneal Chemotherapy , 2004, Clinical pharmacokinetics.

[14]  B. Chauffert,et al.  Using a heating cable within the abdomen to make hyperthermic intraperitoneal chemotherapy easier: feasibility and safety study in a pig model. , 2010, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[15]  Daniel Moga,et al.  Assessment of Temperature Distribution in Intraperitoneal Chemohyperthermia , 2014 .

[16]  Katsuhiko Ogata,et al.  Modern Control Engineering , 1970 .

[17]  H. F. Vanlandingham,et al.  Discretization and Continualization of MIMO Systems , 1993 .